Amgen reported strong second-quarter financial results with significant revenue and earnings growth, alongside raised guidance for the year. The positive outlook is supported by a robust pipeline and strategic restructuring aimed at enhancing long-term growth. These factors are likely to drive a positive short-term movement in the stock.

[1]